Response‐guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: Results from protocol DB AML‐01-Reference-Cited by-同舟云学术

Response‐guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: Results from protocol DB AML‐01

Published:2019-01-08 Issue:5 Volume:66 Page:e27605
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Moerloose Barbara¹²^ORCID,Reedijk Ardine³,Bock Geertruida H⁴,Lammens Tim¹²^ORCID,Haas Valerie³,Denys Barbara⁵,Dedeken Laurence⁶,den Heuvel‐Eibrink Marry M.⁷⁸,te Loo Maroeska⁹,Uyttebroeck Anne¹⁰,Damme An¹¹,der Werff‐ten Bosch Jutte¹²,Zsiros Jozsef¹³,Kaspers Gertjan³⁷¹⁴,Bont Eveline³¹⁵

Affiliation:

1. Department of Pediatric Hematology‐Oncology and Stem Cell TransplantationGhent University Hospital Ghent Belgium

2. Cancer Research Institute Ghent Ghent Belgium

3. Dutch Childhood Oncology Group (DCOG) The Hague the Netherlands

4. Department of EpidemiologyUniversity Medical Center GroningenUniversity of Groningen Groningen the Netherlands

5. Department of Clinical Chemistry, Microbiology and ImmunologyGhent University Hospital Ghent Belgium

6. Department of Pediatric Hematology OncologyHôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles Brussels Belgium

7. Department of Pediatric Hematology‐OncologyPrincess Máxima Center Utrecht the Netherlands

8. Erasmus MC–Sophia Children's Hospital Rotterdam the Netherlands

9. Department of Pediatric Hematology‐OncologyRadboud University Medical Center Nijmegen the Netherlands

10. Department of PediatricsUniversity Hospital Gasthuisberg Leuven Belgium

11. Department of PediatricsUniversity Hospital Saint‐Luc Brussels Belgium

12. Department of Pediatrics, Universitair Ziekenhuis BrusselVrije Universiteit Brussel Brussels Belgium

13. Department of Pediatric Oncology, Amsterdam Medical CenterEmma Children's Hospital Amsterdam the Netherlands

14. Department of Pediatric OncologyVU University Medical Center Amsterdam the Netherlands

15. Department of Pediatric Hematology‐OncologyUniversity Medical Center Groningen, Beatrix Children's Hospital, University of Groningen Groningen the Netherlands

Funder

Stichting Tegen Kanker

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.27605

Reference34 articles.

1. Risk-Stratified Therapy and the Intensive Use of Cytarabine Improves the Outcome in Childhood Acute Myeloid Leukemia: The AML99 Trial From the Japanese Childhood AML Cooperative Study Group

2. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial

3. Response-Guided Induction Therapy in Pediatric Acute Myeloid Leukemia With Excellent Remission Rate